Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol

Diabetes and Vascular Disease Research

Volumn 12, Issue 3, 2015, Pages 208-216

  Joshi, Mandar S ^a,b,c   Williams, David ^a   Horlock, Duncan ^a   Samarasinghe, Thilini ^b   Andrews, Karen L ^a   Jefferis, Ann Maree ^a   Berger, Philip J ^b   Chin Dusting, Jaye P ^a   Kaye, David M ^a,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF KENTUCKY   (United States)

^d ALFRED HOSPITAL   (Australia)

Author keywords

cardiac dysfunction; Diabetes; microvascular; mitochondria; resveratrol

Indexed keywords

NITROPRUSSIDE SODIUM; RESVERATROL; ROTENONE; GLUCOSE BLOOD LEVEL; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CAPILLARY ENDOTHELIAL CELL; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOTHELIAL DYSFUNCTION; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RAT; VASCULAR RING; VASCULARIZATION; ANIMAL; BLOOD; CELL CULTURE; CELL MOTION; COMPLICATION; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DRUG EFFECTS; ENDOTHELIUM CELL; GLUCOSE BLOOD LEVEL; HEART CONTRACTION; ISOLATED HEART; METABOLISM; MICROCIRCULATION; MICROVASCULATURE; MITOCHONDRION; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME; VASODILATATION;

ANIMALS; BLOOD GLUCOSE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; HUMANS; ISOLATED HEART PREPARATION; MALE; MICROCIRCULATION; MICROVESSELS; MITOCHONDRIA; MYOCARDIAL CONTRACTION; RATS, SPRAGUE-DAWLEY; STILBENES; TIME FACTORS; VASODILATION;

EID: 84926462314     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164114565629     Document Type: Article

References (38)

1. Daneman D. Type 1 diabetes. Lancet. 2006 ; 367: 847-858
2. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci. 2005 ; 109: 143-159
3. Babar GS, Zidan H, Widlansky ME, et al. Impaired endothelial function in preadolescent children with type 1 diabetes. Diabetes Care. 2011 ; 34: 681-685
4. Nussbaum C, Cavalcanti Fernandes Heringa A, Mormanova Z, et al. Early microvascular changes with loss of the glycocalyx in children with type 1 diabetes. J Pediatr. 2014 ; 164: 584-589
5. Bulua AC, Simon A, Maddipati R, et al. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med. 2011 ; 208: 519-533
6. Tanaka Y, Konno N, Kako KJ. Mitochondrial dysfunction observed in situ in cardiomyocytes of rats in experimental diabetes. Cardiovasc Res. 1992 ; 26: 409-414
7. Davidson SM. Endothelial mitochondria and heart disease. Cardiovasc Res. 2010 ; 88: 58-66
8. Dedkova EN, Blatter LA. Modulation of mitochondrial Ca2+ by nitric oxide in cultured bovine vascular endothelial cells. Am J Physiol Cell Physiol. 2005 ; 289: C836 - C845
9. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007 ; 2: 329-333
10. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001 ; 414: 813-820
11. Jeninga EH, Schoonjans K, Auwerx J. Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene. 2010 ; 29: 4617-4624
12. Kume S, Uzu T, Kashiwagi A, et al. SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications. Endocr Metab Immune Disord Drug Targets. 2010 ; 10: 16-24
13. Boily G, Seifert EL, Bevilacqua L, et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS ONE. 2008 ; 3: e1759
14. Mattagajasingh I, Kim CS, Naqvi A, et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 2007 ; 104: 14855-14860
15. Tanno M, Kuno A, Horio Y, et al. Emerging beneficial roles of sirtuins in heart failure. Basic Res Cardiol. 2012 ; 107: 273
16. Birrell MA, McCluskie K, Wong S, et al. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J. 2005 ; 19: 840-841
17. Chen YR, Yi FF, Li XY, et al. Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction. Cardiovasc Drugs Ther. 2008 ; 22: 479-485
18. Elmali N, Esenkaya I, Harma A, et al. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res. 2005 ; 54: 158-162
19. Tsuruoka S, Hiwatashi A, Usui J, et al. The mitochondrial SIRT1-PGC-1alpha axis in podocyte injury. Kidney Int. 2012 ; 82: 735-736
20. Gomes AP, Price NL, Ling AJ, et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013 ; 155: 1624-1638
21. Pullen C, Coulson FR, Fenning A. Effects of resveratrol and nebivolol on isolated vascular and cardiac tissues from young rats. Adv Pharmacol Sci. 2014 ; 2014: 720386
22. Du X, Stocklauser-Farber K, Rosen P. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase?. Free Radic Biol Med. 1999 ; 27: 752-763
23. Detaille D, Guigas B, Chauvin C, et al. Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes. 2005 ; 54: 2179-2187
24. Sheu ML, Ho FM, Yang RS, et al. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler Thromb Vasc Biol. 2005 ; 25: 539-545
25. Li N, Ragheb K, Lawler G, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem. 2003 ; 278: 8516-8525
26. Wang X, Qin ZH, Leng Y, et al. Prostaglandin A1 inhibits rotenone-induced apoptosis in SH-SY5Y cells. J Neurochem. 2002 ; 83: 1094-1102
27. Diamant M, Lamb HJ, Groeneveld Y, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol. 2003 ; 42: 328-335
28. Shen X, Zheng S, Thongboonkerd V, et al. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab. 2004 ; 287: E896 - E905
29. Kluge MA, Fetterman JL, Vita JA. Mitochondria and endothelial function. Circ Res. 2013 ; 112: 1171-1188
30. Shenouda SM, Widlansky ME, Chen K, et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation. 2011 ; 124: 444-453
31. Soltesz G, Patterson CC, Dahlquist G. Worldwide childhood type 1 diabetes incidence-what can we learn from epidemiology?. Pediatr Diabetes. 2007 ; 8: 6-14
32. Zoneraich S, Silverman G, Zoneraich O. Primary myocardial disease, diabetes mellitus, and small vessel disease. Am Heart J. 1980 ; 100: 754-755
33. Luttun A, Carmeliet P. De novo vasculogenesis in the heart. Cardiovasc Res. 2003 ; 58: 378-389
34. Soucy NV, Mayka D, Klei LR, et al. Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice. Cardiovasc Toxicol. 2005 ; 5: 29-41
35. Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol. 2000 ; 50: 1-15
36. Tepper OM, Capla JM, Galiano RD, et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood. 2005 ; 105: 1068-1077
37. Yoon YS, Uchida S, Masuo O, et al. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation. 2005 ; 111: 2073-2085
38. Strauer BE, Motz W, Vogt M, et al. Evidence for reduced coronary flow reserve in patients with insulin-dependent diabetes. A possible cause for diabetic heart disease in man. Exp Clin Endocrinol Diabetes. 1997 ; 105: 15-20